chr10-60196628-G-GAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_020987.5(ANK3):​c.1690-5_1690-4dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00653 in 1,247,256 control chromosomes in the GnomAD database, including 51 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 43 hom., cov: 28)
Exomes 𝑓: 0.0058 ( 8 hom. )

Consequence

ANK3
NM_020987.5 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.469

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-60196628-G-GAA is Benign according to our data. Variant chr10-60196628-G-GAA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.013 (1728/133102) while in subpopulation AFR AF = 0.0433 (1609/37128). AF 95% confidence interval is 0.0416. There are 43 homozygotes in GnomAd4. There are 814 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR,Unknown,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.1690-5_1690-4dupTT splice_region_variant, intron_variant Intron 14 of 43 ENST00000280772.7 NP_066267.2 Q12955-3
ANK3NM_001204404.2 linkc.1639-5_1639-4dupTT splice_region_variant, intron_variant Intron 14 of 43 NP_001191333.1 Q12955-4
ANK3NM_001320874.2 linkc.1690-5_1690-4dupTT splice_region_variant, intron_variant Intron 14 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.1672-5_1672-4dupTT splice_region_variant, intron_variant Intron 15 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.1690-4_1690-3insTT splice_region_variant, intron_variant Intron 14 of 43 1 NM_020987.5 ENSP00000280772.1 Q12955-3

Frequencies

GnomAD3 genomes
AF:
0.0130
AC:
1728
AN:
133068
Hom.:
43
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00522
Gnomad ASJ
AF:
0.000627
Gnomad EAS
AF:
0.00149
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.000142
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000246
Gnomad OTH
AF:
0.0118
GnomAD2 exomes
AF:
0.0106
AC:
1204
AN:
113098
AF XY:
0.00923
show subpopulations
Gnomad AFR exome
AF:
0.0613
Gnomad AMR exome
AF:
0.00920
Gnomad ASJ exome
AF:
0.00509
Gnomad EAS exome
AF:
0.00934
Gnomad FIN exome
AF:
0.00365
Gnomad NFE exome
AF:
0.00383
Gnomad OTH exome
AF:
0.00601
GnomAD4 exome
AF:
0.00576
AC:
6415
AN:
1114154
Hom.:
8
Cov.:
21
AF XY:
0.00577
AC XY:
3225
AN XY:
558592
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0540
AC:
1391
AN:
25782
American (AMR)
AF:
0.00607
AC:
197
AN:
32434
Ashkenazi Jewish (ASJ)
AF:
0.00303
AC:
63
AN:
20798
East Asian (EAS)
AF:
0.00510
AC:
169
AN:
33158
South Asian (SAS)
AF:
0.00754
AC:
501
AN:
66432
European-Finnish (FIN)
AF:
0.00217
AC:
80
AN:
36938
Middle Eastern (MID)
AF:
0.00691
AC:
32
AN:
4630
European-Non Finnish (NFE)
AF:
0.00426
AC:
3607
AN:
847342
Other (OTH)
AF:
0.00804
AC:
375
AN:
46640
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.307
Heterozygous variant carriers
0
454
907
1361
1814
2268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0130
AC:
1728
AN:
133102
Hom.:
43
Cov.:
28
AF XY:
0.0127
AC XY:
814
AN XY:
63854
show subpopulations
African (AFR)
AF:
0.0433
AC:
1609
AN:
37128
American (AMR)
AF:
0.00514
AC:
67
AN:
13046
Ashkenazi Jewish (ASJ)
AF:
0.000627
AC:
2
AN:
3192
East Asian (EAS)
AF:
0.00150
AC:
7
AN:
4680
South Asian (SAS)
AF:
0.00143
AC:
6
AN:
4208
European-Finnish (FIN)
AF:
0.000142
AC:
1
AN:
7022
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
268
European-Non Finnish (NFE)
AF:
0.000246
AC:
15
AN:
60986
Other (OTH)
AF:
0.0117
AC:
21
AN:
1790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
79
157
236
314
393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00497
Hom.:
21

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Sep 23, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability-hypotonia-spasticity-sleep disorder syndrome Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.47
Mutation Taster
=99/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34796699; hg19: chr10-61956386; API